CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: terazosin
Accession: CHEBI:9445
browse the term
Definition: A primary amino compound that has formula C19H25N5O4.
Synonyms: exact_synonym: 6,7-dimethoxy-2-[4-(tetrahydrofuran-2-ylcarbonyl)piperazin-1-yl]quinazolin-4-amine
related_synonym: 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine; Formula=C19H25N5O4; InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22); InChIKey=VCKUSRYTPJJLNI-UHFFFAOYSA-N; SMILES=COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1; Terazosine; terazosina; terazosinum
xref: Beilstein:719452; CAS:63590-64-7; DrugBank:DB01162; Drug_Central:3584; KEGG:C07127; KEGG:D08569; LINCS:LSM-4997
xref_mesh: MESH:C041226
xref: Patent:DE2646186; Patent:DE2831112; Patent:US4026894; Patent:US4251532; Wikipedia:Terazosin
G
Adra1a
adrenoceptor alpha 1A
affects binding
EXP ISO
Terazosin binds to ADRA1A protein
CTD
PMID:7536677 PMID:8183249 PMID:21544540
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
G
Adra1b
adrenoceptor alpha 1B
affects binding
ISO
Terazosin binds to ADRA1B protein
CTD
PMID:8183249
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
G
Adra1d
adrenoceptor alpha 1D
affects binding
ISO EXP
Terazosin binds to ADRA1D protein
CTD
PMID:8183249 PMID:9294627
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Terazosin results in increased expression of BAX protein
CTD
PMID:12883741
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Terazosin results in decreased expression of BCL2 protein
CTD
PMID:12883741
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
Terazosin results in increased expression of CDKN1B protein
CTD
PMID:12883741
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Il24
interleukin 24
increases expression
ISO
Terazosin results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Mmp2
matrix metallopeptidase 2
increases activity
EXP
Terazosin increases activity of Mmp2 protein in the prostate
RGD
PMID:16899336
RGD:1601417
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all